Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO) and Syenex, a synthetic biology company specializing in best-in-class targeted delivery technologies,...
Genmab has entered into a binding agreement to acquire Merus, with both companies’ boards unanimously approving the transaction, which is expected to close in...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
Trinity Capital, a leading alternative asset manager, announced the commitment of $45 million in growth capital to Rapid Micro Biosystems, an innovative life sciences...
Genomenon, a leading genomic intelligence company, announced a strategic partnership with Compass Bioinformatics, integrating Genomenon's Mastermind FLEX Data into Compass Bioinformatics' innovative InheriNext platform...
